LYTIR

Company · AURX

Nuo Therapeutics, Inc.

AURX is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($10K); 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. David E. Jorden, CEO/CFO bought on 2 days latest Aug 28, 2026 bought $10K
Every trade (2)
  1. BUYDavid E. Jorden, CEO/CFO bought Aug 28, 2026 7,984 shares filing $9K
  2. BUYDavid E. Jorden, CEO/CFO bought Aug 27, 2026 789 shares filing $844

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Creation of a direct financial obligation; Unregistered sales of equity securities filing Oct 6, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.